Black Diamond Therapeutics, Inc. (BDTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 138.19M |
| Enterprise Value | 135.98M |
| P/E Ratio | -2.09 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.04 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.38 |
| Return On Equity | -0.44 |
Income Statement
| Revenue | 70M |
| Revenue/Share | 0 |
| Gross Profit | 69.68M |
| EBITDA | 22.69M |
| Net Income | 22.37M |
| Diluted EPS | 0.39 |
Balance Sheet
| Total Cash | 102.03M |
| Total Cash/Share | 1.78 |
| Total Debt | 16.04M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 6.92 |
| Book Value Per Share | 1.53 |
Price History
| 52-Week Change | -67.35 |
| 52-Week High | 4.9 |
| 52-Week Low | 1.56 |
| Moving Average 50 Days | 1.88 |
| Moving Average 200 Days | 2.16 |
Statistics
| Average Volume | 687,571 |
| Shares Outstanding | 57.3M |
| % Held by Institutions | 61.37 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
